These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25428394)

  • 1. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.
    Li W; Guan J; Yang L; Zheng X; Yu Y; Jiang J
    Med Oncol; 2015 Jan; 32(1):395. PubMed ID: 25428394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: a retrospective study.
    Li W; Dan G; Jiang J; Zheng Y; Zheng X; Deng D
    Radiat Oncol; 2016 Sep; 11(1):119. PubMed ID: 27623620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
    Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
    Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.
    Yu X; Li J; Zhong X; He J
    BMC Cancer; 2015 Oct; 15():656. PubMed ID: 26445227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
    Colonias A; Betler J; Trombetta M; Bigdeli G; Gayou O; Keenan R; Werts ED; Parda DS
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):105-9. PubMed ID: 20382483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
    Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
    Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
    Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
    Hanna N; Neubauer M; Yiannoutsos C; McGarry R; Arseneau J; Ansari R; Reynolds C; Govindan R; Melnyk A; Fisher W; Richards D; Bruetman D; Anderson T; Chowhan N; Nattam S; Mantravadi P; Johnson C; Breen T; White A; Einhorn L; ;
    J Clin Oncol; 2008 Dec; 26(35):5755-60. PubMed ID: 19001323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC).
    Landreneau JP; Schuchert MJ; Weyant R; Abbas G; Wizorek JJ; Awais O; Reamer MM; Luketich JD; Landreneau RJ
    Surgery; 2014 Feb; 155(2):340-6. PubMed ID: 24314884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lung.
    Fleischman EH; Kagan AR; Streeter OE; Tyrell J; Wollin M; Leagre CA; Harvey JC
    J Surg Oncol; 1992 Jan; 49(1):25-8. PubMed ID: 1312654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma].
    Wang ZM; Wu J; Wang GC; Ren JL; Kjelle D
    Ai Zheng; 2002 Oct; 21(10):1145-8. PubMed ID: 12508663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
    Liu SM; Wang HB; Sun Y; Shi Y; Zhang J; Huang MW; Zheng L; Lv XM; Zheng BM; Reilly KH; Yan XY; Ji P; Wu YF; Zhang JG
    BMC Cancer; 2016 Mar; 16():193. PubMed ID: 26951097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study.
    Nori D; Li X; Pugkhem T
    J Surg Oncol; 1995 Dec; 60(4):257-61. PubMed ID: 8551736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.
    Mutyala S; Stewart A; Khan AJ; Cormack RA; O'Farrell D; Sugarbaker D; Devlin PM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1114-20. PubMed ID: 19540065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.
    Blasberg JD; Belsley SJ; Schwartz GS; Evans A; Wernick I; Ashton RC; Bhora FY; Connery CP
    Ann Thorac Surg; 2010 Feb; 89(2):360-7. PubMed ID: 20103299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy].
    Touboul E; Lagrange JL; Theobald S; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Bréchot J; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Le Chevalier T; Lemarie E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stoebner-Delbarre A; Thiberville L; Vaylet F; Vergnon JM; Westeel V; Depierre A
    Cancer Radiother; 2001 Aug; 5(4):452-63. PubMed ID: 11521393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma.
    Chen A; Galloway M; Landreneau R; d'Amato T; Colonias A; Karlovits S; Quinn A; Santucci T; Kalnicki S; Brown D
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1057-63. PubMed ID: 10421539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
    Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
    Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.